Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Background

Colon cancer is a disease with a worldwide spread. Surgery is the best option for the treatment of advanced colon cancer, but some aspects are still debated, such as the extent of lymphadenectomy. In Japanese guidelines, the gold standard was D3 dissection to remove the central lymph nodes (203, 213, and 223), but in 2009, Hoenberger et al. introduced the concept of complete mesocolic excision, in which surgical dissection follows the embryological planes to remove the mesentery entirely to prevent leakage of cancer cells and collect more lymph nodes. Our study describes how lymphadenectomy is currently performed in major Italian centers with an unclear indication on the type of lymphadenectomy that should be performed during right hemicolectomy (RH).

Methods

CoDIG 2 is an observational multicenter national study that involves 76 Italian general surgery wards highly specialized in colorectal surgery. Each center was asked not to modify their usual surgical and clinical practices. The aim of the study was to assess the preference of Italian surgeons on the type of lymphadenectomy to perform during RH and the rise of any new trends or modifications in habits compared to the findings of the CoDIG 1 study conducted 4 years ago.

Results

A total of 788 patients were enrolled. The most commonly used surgical technique was laparoscopic (82.1%) with intracorporeal (73.4%), side-to-side (98.7%), or isoperistaltic (96.0%) anastomosis. The lymph nodes at the origin of the vessels were harvested in an inferior number of cases (203, 213, and 223: 42.4%, 31.1%, and 20.3%, respectively). A comparison between CoDIG 1 and CoDIG 2 showed a stable trend in surgical techniques and complications, with an increase in the robotic approach (7.7% vs. 12.3%).

Conclusions

This analysis shows how lymphadenectomy is performed in Italy to achieve oncological outcomes in RH, although the technique to achieve a higher lymph node count has not yet been standardized. Trial registration (ClinicalTrials.gov) ID: NCT05943951.

Free full text 


Surg Endosc. 2024; 38(3): 1432–1441.
Published online 2024 Jan 8. https://doi.org/10.1007/s00464-023-10607-8
PMCID: PMC10881627
PMID: 38191814

Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group)

Abstract

Background

Colon cancer is a disease with a worldwide spread. Surgery is the best option for the treatment of advanced colon cancer, but some aspects are still debated, such as the extent of lymphadenectomy. In Japanese guidelines, the gold standard was D3 dissection to remove the central lymph nodes (203, 213, and 223), but in 2009, Hoenberger et al. introduced the concept of complete mesocolic excision, in which surgical dissection follows the embryological planes to remove the mesentery entirely to prevent leakage of cancer cells and collect more lymph nodes. Our study describes how lymphadenectomy is currently performed in major Italian centers with an unclear indication on the type of lymphadenectomy that should be performed during right hemicolectomy (RH).

Methods

CoDIG 2 is an observational multicenter national study that involves 76 Italian general surgery wards highly specialized in colorectal surgery. Each center was asked not to modify their usual surgical and clinical practices. The aim of the study was to assess the preference of Italian surgeons on the type of lymphadenectomy to perform during RH and the rise of any new trends or modifications in habits compared to the findings of the CoDIG 1 study conducted 4 years ago.

Results

A total of 788 patients were enrolled. The most commonly used surgical technique was laparoscopic (82.1%) with intracorporeal (73.4%), side-to-side (98.7%), or isoperistaltic (96.0%) anastomosis. The lymph nodes at the origin of the vessels were harvested in an inferior number of cases (203, 213, and 223: 42.4%, 31.1%, and 20.3%, respectively). A comparison between CoDIG 1 and CoDIG 2 showed a stable trend in surgical techniques and complications, with an increase in the robotic approach (7.7% vs. 12.3%).

Conclusions

This analysis shows how lymphadenectomy is performed in Italy to achieve oncological outcomes in RH, although the technique to achieve a higher lymph node count has not yet been standardized.

Trial registration (ClinicalTrials.gov) ID: NCT05943951.

Keywords: Right hemicolectomy, Ileocolic anastomosis, Laparoscopy, Lymphadenectomy, CME, Outcomes

Colon cancer is the second most common cancer in women and the third most common cancer in men [1].

The best option for treating advanced colon cancer without distant metastasis is surgery. However, the best surgical course of action is still under debate, with the extension of lymphadenectomy being one of the most contentious issues [2, 3].

While it has been demonstrated that the laparoscopic approach for colon cancer surgery is comparable to open surgery in terms of safety and oncological outcomes [4], the type of lymphadenectomy that must be performed does not have the same scientific certainty. Since the 1980s, for colon cancer with a stage higher than T2, Japanese guidelines have recommended removing the central lymph nodes (D3 dissection) during colectomy [5], but in 2009, Hohenberger et al. [6] introduced the concept of complete mesocolic excision (CME). They emphasized that surgical dissection must strictly follow the embryological planes to remove the diseased colon and its mesentery as a unit and prevent the leakage of cancer cells. To date, there have been several studies, with others in progress [7], comparing these two techniques. Recently, we have seen that the CME procedure harvests a larger area of the mesentery and more lymph nodes, but the duration of surgery is longer with CME than with D2 [2, 8, 9]. CME does not increase the intraoperative and postoperative complications of laparoscopic right hemicolectomy (RH); however, the risk of vascular injury during CME is significantly increased [2]. With the data now available, it is not possible to verify with certainty that CME has improved oncological survival; it has not been shown to be less feasible and less safe than standard surgery, but it is a more complex and difficult procedure, requiring more operative experience and a longer learning curve [10, 11].

Adding to these promising oncological benefits, the CME procedure offers increased accuracy for patient stadiation through removal and analysis of lymph nodes from stations that are not considered in traditional RH, provided increased possibilities of detecting nodal metastases that otherwise go unnoticed, as nodal spread does not always start from the stations more proximal to the primitive lesion [12, 13]. Our study aims to provide a picture of how lymphadenectomy is currently performed in many Italian centers in an international scenario where indications are mostly unclear, especially regarding the type of lymphadenectomy that should be performed during RH (Fig. (Fig.11).

An external file that holds a picture, illustration, etc.
Object name is 464_2023_10607_Fig1_HTML.jpg

Lymph node locations. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma—3rd English edition, 2019

Materials and methods

Study design

The CoDIG 2 (ColonDx Italian Group—Italian Right Colon Group) study was designed as a cohort, prospective, observational, multicenter national study comparing the risk of postoperative complications during RH to the extent of the lymphadenectomy that is performed. Patients were recruited over a 6-month period from April 2022 to October 2022. The study was approved by SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie—Italian Society of Endoscopic Surgery and New Technologies). The Coordinator Center and Promoter of the study is the 1st Department of General Surgery of Ferrara University Hospital. The study involved 76 Italian general surgery centers that are highly specialized in colorectal surgery. Data were collected using the official SICE website database. Each center was asked not to modify their traditional surgical and clinical practices, including the technologies used, the surgical approach, the lymphadenectomies performed, and the pre- and postoperative management (including the ERAS, Enhanced Recovery After Surgery, protocol). Patients involved in the study signed an informed consent form. The primary endpoint of the study was to assess the preference of Italian surgeons on the type of lymphadenectomy to perform during RH and its results in terms of lymph node harvest. The secondary endpoint was to compare CoDIG 1 and CoDIG 2 in terms of surgical techniques used, anastomosis and postoperative outcomes to describe the evolution of right colon surgery in Italy after 4 years.

Population and inclusion and exclusion criteria

Each center was committed to enrolling all consecutive patients observed during the study period aged > 18 years old who underwent elective laparoscopic or robotic RH.

The exclusion criteria were emergency surgery, laparotomic RH, ASA > IV, and pregnancy.

The online collection (SICE website database) of the data for each patient enrolled included the following:

  • Patient characteristics: sex, age, BMI, Charlson comorbidity index.

  • Indication for surgery: ASA score, preoperative diagnosis, TNM stage, histologic diagnosis.

  • Intraoperative data: surgical technique, operative time, type of anastomosis, and intraoperative complications.

  • Pathological anatomy information: tumor-free margin, terminal ileum length, vascular ligature, mesocolon sail integrity and area, and total lymph nodes/positive lymph nodes.

  • Postoperative management: ERAS protocol adherence, postoperative hospital stay, postoperative complications.

A total of 788 patients were recruited by the 76 participating centers over a period of 6 months from April 2022 to October 2022.

Complete lymphadenectomy vs. incomplete lymphadenectomy

To conduct a comparative analysis in a nonrandomized real-life study setting, a series of variables regarding the surgical technique of lymphadenectomy was used to divide the patients into two groups, one in which the basic principles of an allegedly correct lymphadenectomy were adhered to and one in which at least one factor was not adhered to. The factors considered were ligation at the origin of the ileocolic artery, ligation at the origin of the right branch of the medium colic artery, integrity of the mesocolic sail [3, 6] and tumor-free margin > 5 cm [14]. Two groups were then created: Group C (complete lymphadenectomy) included the patients in whom all variables were achieved, and Group I (incomplete lymphadenectomy) included the patients in whom one or more of these quality landmarks were not achieved.

Statistical analysis

The data are expressed as the median and interquartile range for quantitative variables and absolute and relative frequencies for qualitative variables. To analyze differences between groups, the Wilcoxon test was utilized for numerical features, while the chi-square test or, if suitable, Fisher’s exact test was used for categorical features.

A multivariable gamma model was calculated for the overall number of lymph nodes, taking into account the skewed nature of the response variable. The impacts of unit increases were documented along with their 95% confidence intervals, achieved by calculating the marginal effect through a partial derivative of the expected value. Furthermore, a multivariable zero-inflated beta model was applied to the proportion of positive lymph nodes. This model addressed how the covariates influenced both the proportion of positive lymph nodes (beta regression) and the likelihood of encountering no positive lymph nodes out of the total count during the procedure (zero inflation).

The computations were performed with R 3.4.2 with the gamlss[1] and rms[2] packages.

Results

Seven hundred eighty-eight patients were enrolled; 370 (47.0%) were male, and 418 (53.0%) were female, with an average age of 74 years. Regarding BMI, 1.78% had BMI scores < 18, 47% had BMI scores between 18 and 24, 38.2% had BMI scores between 25 and 30, and 13.1% had BMI scores over 30. The overall population had a median Charlson comorbidity score of 5 points. Previous abdominal surgery had occurred in 364 patients (46.2%). The indications for elective right hemicolectomy were benign disease in 39 cases (4.95%) and malignant disease in 749 cases (95.1%). According to the American Society of Anesthesiologists (ASA) score, 3.43% were ASA I, 45.6% were ASA II, 44.7% were ASA III, and 6.35% were > ASA III (Table (Table11).

Table 1

Patient characteristics

Tot (788)Complications
Yes (619)No (169)
n (%)
Sex
 Male370 (47.0%)300 (48.5%)70 (41.4%)
 Female418 (53.0%)319 (51.5%)99 (58.6%)
Age74.0 [67.0;81.0]74.0 [66.0;80.0]76.0 [71.0;82.0]
BMI
 < 1814 (1.78%)13 (2.10%)1 (0.59%)
 18–24370 (47.0%)288 (46.5%)82 (48.5%)
 25–30301 (38.2%)240 (38.8%)61 (36.1%)
 > 30103 (13.1%)78 (12.6%)25 (14.8%)
ASA score
 I27 (3.43%)25 (4.04%)2 (1.18%)
 II359 (45.6%)292 (47.2%)67 (39.6%)
 III352 (44.7%)271 (43.8%)81 (47.9%)
 > III50 (6.35%)31 (5.01%)19 (11.2%)
Charlson comorbidity score5.00 [3.00;6.00]5.00 [3.00;6.00]6.00 [4.00;7.00]
Previous abdominal surgery
 Yes364 (46.2%)284 (45.9%)80 (47.3%)
 No424 (53.8%)335 (54.1%)89 (52.7%)
Pathology
 Benign39 (4.95%)35 (5.65%)4 (2.37%)
 Malignant749 (95.1%)584 (94.3%)165 (97.6%)

Surgical techniques

The most commonly used surgical technique was laparoscopic in 82.1% of patients, and alternative robotic surgery and video-assisted techniques were performed in 11.5% and 6.35% of patients, respectively. Robotic surgery involves the use of a robotic device, while video-assisted surgery refers to a hybrid laparoscopic technique with anastomosis performed through service access. Regarding operating time, less than 180 min was needed in 52.3% of patients, 180–270 min in 37.2%, and more than 270 min in 10.5%. Blood transfusion was necessary in 28 patients (3.55%). ICA was performed in 578 (73.4%) patients, while ECA was performed in 210 (26.6%) patients. Side-to-side (98.7%) and isoperistaltic (96.0%) anastomosis were the most common techniques. Mesocolon closure was performed in less than half of patients (48.0%), with interrupted sutures in 87 patients and continuous sutures in 291 patients (11.0% and 36.9% of all patients, respectively). Among alternatives to specimen extraction, a Pfannenstiel incision was most common at 53.0%, followed by a median upper umbilical incision at 25.1%. The rate of conversion was 7.49% (Table (Table22).

Table 2

Descriptive analysis of intervention variables and surgical techniques

VariablesTypen (%)
Surgical techniqueLaparoscopic647 (82.1%)
Robotic91 (11.5%)
Video assisted50 (6.35%)
Surgery time> 270 min83 (10.5%)
181–270 min293 (37.2%)
90–180 min412 (52.3%)
Need for blood transfusionNo760 (96.4%)
Yes28 (3.55%)
AnastomosisIntracorporeal (ICA)578 (73.3%)
Extracorporeal (ECA)210 (26.7%)
TailoringL–L778 (98.7%)
Other10 (1.27%)
DirectionIsoperistaltic747 (96.0%)
Anisoperistaltic31 (3.98%)
ICAManual26 (3%)
Mechanical836 (97%)
ECAManual122 (33.6%)
Mechanical241 (66.4%)
Enterotomy closureManual722 (91.6%)
Mechanical66 (8.38%)
Enterotomy manual closureSingle layer111 (15.4%)
Double layer611 (84.6%)
Mesocolon closureNo410 (52.0%)
Yes, interrupted suture87 (11.0%)
Yes, continuous suture291 (36.9%)
Specimen extraction incisionPfannenstiel418 (53.0%)
Median subumbilical56 (7.11%)
Median upper umbilical198 (25.1%)
Transverse right hypochondrium40 (5.08%)
Other76 (9.64%)
ConversionYes59 (7.49%)
No729 (92.5%)

CoDIG 1 vs. CoDIG 2

Some variables were compared between CoDIG 1 [15] and CoDIG 2. Regarding the surgical technique, there was a slight reduction in the laparoscopic technique in favor of the robotic approach (laparoscopic 92.3% vs. 87.7%; robotic 7.7% vs. 12.3%). Regarding anastomosis, an increase of 3% in intracorporeal anastomosis (ICA), which is mainly performed with mechanical staplers, was observed, confirming the previous data of CoDIG 1 [15]. The results of intraoperative and postoperative complications are similar, with a relative increase in intraoperative complications in CoDIG 2. The comparison of comparable data after 4 years between the two studies shows a stable trend in surgical technique and complications, with the exception of the robotic approach, which has been increasing in recent years (Table (Table33).

Table 3

Comparison of CoDIG 1 vs. CoDIG 2

VariablesTypeCoDIG 1CoDIG 2
Technique usedLaparoscopic1131 (92.3%)647 (87.7%)
Robotic94 (7.7%)91 (12.3%)
AnastomosisICA862 (70.4%)578 (73.3%)
ECA363 (29.6%)210 (26.7%)
ICAManual26 (3%)22 (3.8%)
Mechanical836 (97%)556 (96.2%)
ECAManual122 (33.6%)81 (38.6%)
Mechanical241 (66.4%)129 (61.4%)
Intraoperative complications20 (1.6%)24 (4.2%)
Intraperitoneal hemorrhages(1.3%)(1.6%)
Iatrogenic small bowel lesion(0.3%)(1.2%)
Postoperative complicationsAnastomotic bleeding(4%)(3.5%)
Anastomotic leakage(2.2%)(2.8%)
Bowel obstruction(1.7%)(3.7%)
Intra-abdominal abscess(1.8%)(3.8%)
Wound infection(4.3%)(4.4%)

Lymphadenectomy

A tumor-free margin greater than 5 cm was achieved in most patients (89.9%), while a terminal ileum > 10 cm was achieved in only 43.4% of patients. Ligation at the origins of the colic vessels was preferred in 96.9% of patients for the ileocolic artery, 70.1% of patients for the right colic artery, and 67.8% of patients for the right branch of the medium colic artery. The integrity of the mesocolic sail was preserved in 88.3% of patients. The average number of harvested lymph nodes was 23. According to the Benz score [16], most specimens were type I (49.4%), followed by type 0 (37.6%), type II (11.2%) and type III (1.8%) (Table (Table44).

Table 4

Lymphadenectomy

Tumor-free margin < 5 cm79 (10.1%)
 > 5 cm709 (89.9%)
Terminal ileum < 10 cm446 (56.6%)
 > 10 cm342 (43.4%)
Ligation at the origin of the ileocolic arteryYes764 (96.9%)
No24 (3.1%)
Ligation at the origin of the right colic arteryYes552 (70.1%)
No236 (29.9%)
Ligation at the origin of the right branch of the medium colic arteryYes534 (67.8%)
No254 (32.2%)
Integrity of the mesocolic sailYes696 (88.3%)
No92 (11.7%)
Number of lymph nodes harvestedAverage23
Number of positive lymph nodesAverage1.45
Benz score [16]Type 0297 (37.6%)
Type I389 (49.4%)
Type II88 (11.2%)
Type III14 (1.8%)

Pathologist reports were consulted to identify the lymph node areas that were most commonly collected during RH surgery. Stations 201, 211 and 221, which are the most proximal to the colonic wall lymph node stations, were more frequently collected (87.9%, 86.2%, and 68.9% of cases, respectively). Similarly, the lymph nodes along the colic vessels (202, 212, and 222; 88.2%, 81.5%, and 64.7%, respectively) were among the most frequently found in specimens, while the lymph nodes at the origins of the vessels were harvested in an inferior number of cases (203, 213, and 223; 42.4%, 31.1%, and 20.3%, respectively) (Table (Table55).

Table 5

Areas of lymphadenectomy

201693 (87.9%)
202695 (88.2%)
203334 (42.4%)
211679 (86.2%)
212642 (81.5%)
213245 (31.1%)
221543 (68.9%)
222510 (64.7%)
223160 (20.3%)

Complete lymphadenectomy vs. incomplete lymphadenectomy

According to the reported data, in Italy, ligation at the origins of the ileocolic and right branch of the middle colic arteries, tumor-free margins > 5 cm and integrity of the mesocolic sail (Group C) are achieved in 55% of cases compared to 45% of cases in which at least one of these variables is not met (Group I). The stratified sample was homogeneous in terms of variables such as sex, age and BMI, with no statistically significant differences. Surgical technique also showed no statistically significant differences in distribution among laparoscopic, robotic and video-assisted procedures in the two groups (Table (Table66).

Table 6

Group C vs. Group I

NoTotalGroup CGroup Ip value
N = 749N = 412 (55%)N = 337 (45%)
Sex0.619
 F347 (46.3%)187 (45.4%)160 (47.5%)
 M402 (53.7%)225 (54.6%)177 (52.5%)
Age74.0 [67.0;81.0]74.0 [67.0;81.0]75.0 [68.0;82.0]0.304
BMI0.913
 BMI < 3014 (1.87%)7 (1.70%)7 (2.08%)
 BMI > 30735 (98.1%)405 (98.3%)330 (97.9%)
Surgical technique0.174
 Laparoscopic610 (81.4%)328 (79.6%)282 (83.7%)
 Robotic90 (12.0%)51 (12.4%)39 (11.6%)
 Video assisted49 (6.54%)33 (8.01%)16 (4.75%)
 Blood loss (ml)70.0 [30.0;120]77.5 [40.0;130]60.0 [30.0;100]0.114
 Number of lymph nodes removed22.0 [16.0;27.0]22.0 [17.0;28.0]21.0 [15.0;26.0]0.002
 Lymph nodes removed positive0.00 [0.00;1.00]0.00 [0.00;2.00]0.00 [0.00;1.00]0.183
 Number of positive lymph nodes252 (33.6%)152 (36.9%)100 (29.7%)0.045
 Postoperative complications (< 30 days)165 (22.0%)79 (19.2%)86 (25.5%)0.046
pTNM stage [American Joint Committee on Cancer (AJCC) Ed. IX]0.011
 I200 (26.7%)92 (22.3%)108 (32.0%)
 II277 (37.0%)161 (39.1%)116 (34.4%)
 III–IV272 (36.3%)159 (38.6%)113 (33.5%)
Benz score [16]< 0.0001
 Type 0283 (37.8%)201 (48.8%)82 (24.3%)
 Type I372 (49.7%)191 (46.4%)181 (53.7%)
 Type II80 (10.7%)18 (4.3%)62 (18.4%)
 Type III14 (1.8%)2 (0.5%)12 (3.6%)

Benign lesions were excluded

Regarding the estimated intraoperative blood loss, there was no statistically significant difference between Groups C and I [Group C: 77.5 ml (40.0;130); Group I: 60.0 ml (30.0;100) p: 0.114].

The difference in both the number of lymph nodes harvested [Group C: 22.0 (17.0;28.0); Group I: 21.0 (15.0;26.0); p: 0.002] and the positive lymph nodes found on anatomopathological examination [Group C: 152 (36.9%); Group I: 100 (29.7%) p: 0.045] between the two groups was statistically significant.

We observed an increase in the number of registered complications at 30 days in Group I compared to Group C [Group C: 79 (19.2%); Group I: 86 (25.5%); p: 0.046] Finally, stratification by stage showed that a more complete procedure (Group C) was preferred in the more advanced stages (Stage III–IV: Group C, 38.6% vs. Group I, 33.5%; Stage II: Group C, 39.1% vs. Group I, 34.4%; p value 0.011) compared to the less advanced stages, where the less complete procedure was preferred (Group I, 32% vs. Group C, 22.3%; p value 0.011).

The correct division of patients was also confirmed by comparing the completeness of the surgical procedure with the Benz score, which showed a greater number of patients with extensive resection of the mesocolon in Group C (Type 0: Group C, 48.8% vs. Group I, 24.3%; p value < 0.0001) and a greater number of patients with less extensive resection in Group I (Type II: Group C, 4.3% vs. Group I, 18.4%; Type III: Group C, 0.5% vs. Group I, 3.6%; p value < 0.0001).

Discussion

In recent years, since the number of recovered lymph nodes has been determined to significantly affect oncological prognosis, the extent of lymph node dissection during RH has attracted the attention of many colorectal surgeons [17] and has been a controversial point of discussion. This is due to a lack of agreement over the appropriate use of D2, D3 or CME dissection, which are often used interchangeably in the evaluation of anatomical landmarks and oncological qualities [1820]. Since a compromise between increased morbidity and survival must be carefully considered, a standardized approach to choose among these procedures is becoming increasingly necessary [17]. In addition, a common standardized evaluation of the surgical area in relation to the completeness of CME is also necessary; the classification proposed by Benz et al., which we used in our study, could be a useful tool [16]. To provide more evidence to settle this debate, the Scientific Committee of SICE performed this observational prospective cohort study to collect data and provide a picture of how lymphadenectomy is currently performed in major Italian colorectal centers. The results of the survey demonstrated that the large majority of the Italian surgeons in this study have tried to achieve an oncologically correct lymphadenectomy by leaving a tumor-free margin greater than 5 cm, performing ligation at the origins of the colic vessels and maintaining the integrity of the mesocolic sail [21]; the achievement of all four variables in the same patient (Group C) is obtained in 55% of all right hemicolectomies.

In the two groups, there were no obvious differences in surgical technique (laparoscopic, robotic, or video-assisted) or amount of blood loss. A greater number of lymph nodes were harvested in Group C [Group C: 22.0 (17.0;28.0); Group I: 21.0 (15.0;26.0); p: 0.002], and more positive lymph nodes were found on anatomopathological examination [Group C: 152 (36.9%); Group I: 100 (29.7%) p: 0.045]. These results confirm the efficacy in lymph node harvesting during more invasive and complete lymphadenectomy compared to less aggressive lymphadenectomies. In addition, procedures with a complete lymphadenectomy are more widely used in oncologic disease with the more advanced pTNM Stages II and III–IV than in Stage I, in which lymphadenectomy is less likely to meet all criteria. These data show the different extent of lymphadenectomy depending on the stage of disease in a real-life scenario and how the disease stage influences the surgeon’s choices, tending to opt for a more complete lymphadenectomy in more advanced stages. However, 30-day postoperative complications were higher in Group I [Group C: 79 (19.2%); Group I: 86 (25.5%); p: 0.046]. This unexpected finding may be explained by the assumption that more invasive procedures are performed by more experienced surgeons with complete learning curves and are less prone to complications. The correct division of patients was also confirmed by the analysis of the anatomopathological results according to the Benz score, which showed a higher quality in Group C than in Group I.

The centers involved in the study requested data on which lymph node stations were collected during surgery, and lymph node stations along the axis of the superior mesenteric vessels were found to be the least frequently collected (203, 213, and 223; 42.4%, 31.1%, and 20.3%, respectively). This finding highlights that the role of central lymphadenectomy, which is riskier from the point of view of surgical safety, is still controversial; in fact, many Italian surgeons do not consider this procedure necessary to ensure complete lymphadenectomy, despite adhering to the principles used in our evaluation and indicated by the Benz score. Randomized studies on the benefits of removing the most central lymph node stations in both stadiation and therapy and the impact on patient survival are needed to increase understanding and to standardize and unify the procedure.

The data concerning the surgical technique showed a more widespread use of robotic technology and ICA 4 years after the first CoDIG study, outlining this direction for the future.

Conclusion

This multicentric prospective observational study, with its inherent limitations, did not aim to define the standard of lymphadenectomy during RH but attempted to obtain a picture of how lymphadenectomy is performed in Italy and the direction of RH as a surgical procedure.

In 55% of cases, a complete lymphadenectomy (a lymphadenectomy that includes ligation at the origin of the colic vessels, maintenance of the mesocolic sail and disease-free resection margins > 5 cm) is performed, and this results in greater numbers of lymph nodes excised and positive lymph nodes. This choice is guided by the stage of disease, with surgeons showing a preference for more complete lymphadenectomies in more advanced stages.

While surgeons lean toward an extended lymphadenectomy for right colon cancer, the technique to achieve a higher lymph node count has not yet been standardized. RCTs, many of which are now ongoing, are needed to identify a common direction on the type of lymphadenectomy to be performed.

Acknowledgements

The study was approved by the Ethical Committee of the province of Ferrara, authorized by the Azienda Ospedaliero-Universitaria of Ferrara with the Protocol CE 890/2020/OSS/AOUFe, and registered on clinicaltrials.gov (NCT05943951).

SICE CoDIG 2 (ColonDx Italian Group)*: *V. Adamo (Vercelli), *M. Ammendola (Catanzaro), *P. Angelini (Napoli), *M. Annecchiarico (Benevento), *G. Aprea (Napoli), *F. Autori (Iglesias, SU), *G. Baldazzi (Legnano, MI), *A. Balla (Civitavecchia, Roma), *G. Baronio (Esine, BS), *G. Bellio (Piove di Sacco, PD), *G. Bertelli (Bolzano), *C. Bima (Torino), *L. D. Bonomo (Borgosesia, VC), *D. Borreca (Torino), *E. Botteri (Montichiari), *A. Brescia (Roma), *L. Cafagna (Andria), *P. Capelli (Piacenza), *V. Caracino (Pescara), *M. Caricato (Roma), *M. Carlini (Roma), *E. Cassinotti (Milano), *M. Catarci (Roma), *P. Chiaro (Torino), *N. Cillara (Cagliari), *M. Clementi (Aquila), *R. B. Contul (Aosta), *G. Curro (Catanzaro), *N. De Manzini (Trieste), *M. Degiuli (Orbassano, TO), *D. Delogu (Sassari), *A. Di Leo (Trento), *U. Elmore (Milano), *G. Ercolani (Forlì), *F. Festa (Torino), *R. Galleano (Savona), *G. Gambino (Trapani), *R. Gelmini (Modena), *A. Giordano (Prato), *R. La Mendola (Rovigo), *L. Laface (Carate Brianza, MB), *L. Masoni (Roma), *A. Maurizi (Jesi), *R. Memeo (Acquaviva delle Fonti, Bari), *P. Mercantini (Roma), *G. Merola (Frattamaggiore, NA), *M. Milone (Napoli), *M. Montuori (Ponte San Pietro, BG), *L. Morelli (Pisa), *I. A. Muttillo (Roma), *R. Nascimbeni (Brescia), *T. Nelli (Firenze), *S. Olmi (Bergamo), *M. Ortenzi (Ancona), *A. Patriti (Pesaro), *G. Pavone (Foggia), *M. Pisano (Cagliari), *R. Polastri (Biella), *D. Rega (Napoli), *M. Rottoli (Bologna), *E. Saladino (Messina), *M. Santarelli (Torino), *R. Santoro (Viterbo), *A. Sartori (Montebelluna, TV), *M. Scatizzi (Bagno a Ripoli, FI), *G. Sica (Roma), *W. Siquini (Macerata), *M. Sorrentino (Latisana, UD), *F. Staderini (Firenze), *L. Vincentini (Castellana Grotte, BA), G. Aizza (Trieste), M. Ammendola (Catanzaro), P. Amodio (Viterbo), F. Aquilino (Castellana Grotte, BA), G. Argenio (Benevento), A. Avanzolini (Forlì), L. Baldari (Milano), F. Banchini (Piacenza), M. Benedetti (Roma), V. Bertino (Trapani), A. Bianco (Biella), F. Blasi (Roma), L. Bonariol (Montebelluna), D. Bono (Borgosesia, VC), A. Bottari (Firenze), S. Buscemi (Palermo), G. Calini (Bologna), R. Campagnacci (Jesi), S. Cantafio (Prato), G. T. Capolupo (Roma), M. Capuano (Napoli), F. Carannante (Roma), M. Casati (Carate Brianza, MB), D. Cassini (Legnano, MI), S. Castiglioni (Macerata), C. Cecconi (Piove di Sacco, PD), L. Cestino (Torino), N. Chetta (Acquaviva delle fonti, BA), F. M. Chiappetta (Ponte San Pietro, BG), L. Cinelli (Milano), A. Cojutti (Latisana, UD), D. Colettta (Pesaro), D. Corallino (Pesaro), L. Crepaz (Trento), S. Curcio (Catanzaro), G. Cuticone (Papardo, ME), F. D’Agostino (Cagliari), M. De Luca (Rovigo), G. D. De Palma (Napoli), C. De Rosa (Vercelli), A. De Serra (Cagliari), R. Del Giudice (Esine, BS), G. Di Franco (Pisa), F. Foglio (Roma), G. Fontani (Firenze), L. Fortuna (Firenze), M. R. Fortunato (Aosta), D. Frazzini (Pescara), N. Furbetta (Pisa), E. Gambino (Savona), I. Garosio (Brescia), P. Germani (Trieste), O. Ghazouani (Savona), D. Giannotti (Viterbo), E. Gibin (Torino), A. Grasso (L’Aquila), M. Grieco (Roma), D. Izzo (Napoli), G. G. Laracca (Roma), G. Lauteri (Roma), P. Lepiane (Civitavecchia), F. S. Li Causi (Roma), E. Locci (Cagliari), G. Lorenzo (Milano), A. Madaro (Acquaviva delle fonti, BA), F. Madeddu (Iglesias, SU), F. Maggi (Roma), F. Maiello (Biella), M. Manigrasso (Napoli), R. Marcellinaro (Roma), P. Marinello (Bolzano), M. S. Mattei (Roma), G. Mazzarella (Roma), G. Merola (Frattamaggiore, NA), F. Moroni (Prato), A. Murgese (Torino), E. M. Muttillo (Roma), A. Oldani (Bergamo), M. Paicilli (Foggia), M. Palmieri (Ancona), G. Palomba (Napoli), G. Paolini (Firenze), D. Parini (Rovigo), G. M. Paroli (Bagno a Ripoli, FI), M. Pellicciaro (Roma), N. Petrucciani (Roma), B. Picardi (Roma), R. Piccolo (Latisana, UD), E. Pinotti (Ponte San Pietro, BG), A. Pisanu (Cagliari), R. Reddavid (Orbassano, TO), A. Resendiz (Orbassano, TO), G. Romano (Palermo), E. G. Rossi (Modena), R. Saracco (Napoli), R. Scaramuzzo (Civitavecchia), F. Serra (Modena), E. Sgotto (Torino), L. Solaini (Forlì), M. Spalluto (Legnano, MI), L. Taglietti (Esine, BS), E. Tartaglia (Napoli), N. Tartaglia (Foggia), B. Torre (Bologna), R. Tutino (Torino), M. Varesano (Andria), N. Vettoretto (Montichiari), E. Villamaina (Frattamaggiore, NA), T. Viora (Torino), M. Yusef (Roma), M. Zago (Borgosesia, VC), A. Zerbinati (Piove di Sacco, PD).

Funding

Open access funding provided by Università degli Studi di Ferrara within the CRUI-CARE Agreement.

Declarations

Disclosures

G. Anania, M. Chiozza, A. Campagnaro, F. Bagolini, G. Resta, D. Azzolina, G. Silecchia, R. Cirocchi, A. Agrusa, D. Cuccurullo, and M. Guerrieri have no conflicts of interest or financial ties to disclose.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

G. Anania and M. Chiozza share first authorship of the manuscript.

Contributor Information

SICE CoDIG (ColonDx Italian Group):

V. Adamo, M. Ammendola, P. Angelini, M. Annecchiarico, G. Aprea, F. Autori, G. Baldazzi, A. Balla, G. Baronio, G. Bellio, G. Bertelli, C. Bima, L. D. Bonomo, D. Borreca, E. Botteri, A. Brescia, L. Cafagna, P. Capelli, V. Caracino, M. Caricato, M. Carlini, E. Cassinotti, M. Catarci, P. Chiaro, N. Cillara, M. Clementi, R. B. Contul, G. Curro, N. De Manzini, M. Degiuli, D. Delogu, A. Di Leo, U. Elmore, G. Ercolani, F. Festa, R. Galleano, G. Gambino, R. Gelmini, A. Giordano, R. La Mendola, L. Laface, L. Masoni, A. Maurizi, R. Memeo, P. Mercantini, G. Merola, M. Milone, M. Montuori, L. Morelli, I. A. Muttillo, R. Nascimbeni, T. Nelli, S. Olmi, M. Ortenzi, A. Patriti, G. Pavone, M. Pisano, R. Polastri, D. Rega, M. Rottoli, E Saladino, M. Santarelli, R. Santoro, A. Sartori, M. Scatizzi, G. Sica, W. Siquini, M. Sorrentino, F. Staderini, L. Vincentini, G. Aizza, M. Ammendola, P. Amodio, F. Aquilino, G. Argenio, A. Avanzolini, L. Baldari, F. Banchini, M. Benedetti, V. Bertino, A. Bianco, F. Blasi, L. Bonariol, D. Bono, A. Bottari, S. Buscemi, G. Calini, R. Campagnacci, S. Cantafio, G. T. Capolupo, M. Capuano, F. Carannante, M. Casati, D. Cassini, S. Castiglioni, C. Cecconi, L. Cestino, N. Chetta, F. M. Chiappetta, L. Cinelli, A. Cojutti, D. Colettta, D. Corallino, L. Crepaz, S. Curcio, G. Cuticone, F. D’Agostino, M. De Luca, G. D. De Palma, C. De Rosa, A. De Serra, R. Del Giudice, G. Di Franco, F. Foglio, G. Fontani, L. Fortuna, M. R. Fortunato, D. Frazzini, N. Furbetta, E. Gambino, I. Garosio, P. Germani, O. Ghazouani, D. Giannotti, E. Gibin, A. Grasso, M. Grieco, D. Izzo, G. G. Laracca, G. Lauteri, P. Lepiane, F. S. Li Causi, E. Locci, G. Lorenzo, A. Madaro, F. Madeddu, F. Maggi, F. Maiello, M. Manigrasso, R. Marcellinaro, P. Marinello, M. S. Mattei, G. Mazzarella, G. Merola, F. Moroni, A. Murgese, E. M. Muttillo, A. Oldani, M. Paicilli, M. Palmieri, G. Palomba, G. Paolini, D. Parini, G. M. Paroli, M. Pellicciaro, N. Petrucciani, B. Picardi, R. Piccolo, E. Pinotti, A. Pisanu, R. Reddavid, A. Resendiz, G. Romano, E. G. Rossi, R. Saracco, R. Scaramuzzo, F. Serra, E. Sgotto, L. Solaini, M. Spalluto, L. Taglietti, E. Tartaglia, N. Tartaglia, B. Torre, R. Tutino, M. Varesano, N. Vettoretto, E. Villamaina, T. Viora, M. Yusef, M. Zago, and A. Zerbinati

References

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. 10.3322/caac.21492. [Abstract] [CrossRef] [Google Scholar]
2. Xu L, Su X, He Z, Zhang C, Lu J, Zhang G, Sun Y, Du X, Chi P, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Z, Zheng M, Xiao Y, RELARC Study Group Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial. Lancet Oncol. 2021;22(3):391–401. 10.1016/S1470-2045(20)30685-9. [Abstract] [CrossRef] [Google Scholar]
3. Sica GS, Vinci D, Siragusa L, Sensi B, Guida AM, Bellato V, García-Granero Á, Pellino G. Definition and reporting of lymphadenectomy and complete mesocolic excision for radical right colectomy: a systematic review. Surg Endosc. 2023;37(2):846–861. 10.1007/s00464-022-09548-5. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
4. Guillou PJ, Quirke P, Thorpe H, et al. Short­term endpoints of conventional versus laparoscopic­assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. The Lancet. 2005;365:1718–1726. 10.1016/S0140-6736(05)66545-2. [Abstract] [CrossRef] [Google Scholar]
5. Dennosuke J. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Jpn J Surg. 1983;13:557–573. 10.1007/BF02469505. [Abstract] [CrossRef] [Google Scholar]
6. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Colorectal Dis. 2009;11:354–364. 10.1111/j.1463-1318.2008.01735.x. [Abstract] [CrossRef] [Google Scholar]
7. Degiuli M, Solej M, Resendiz Aguilar HA, Marchiori G, Reddavid R. Complete mesocolic excision in comparison with conventional surgery for right colon cancer: a nationwide multicenter study of the Italian Society of Surgical Oncology colorectal cancer network (CoME-in trial). Study protocol for a randomized controlled trial. Jpn J Clin Oncol. 2022;52(10):1232–1241. 10.1093/jjco/hyac116. [Abstract] [CrossRef] [Google Scholar]
8. Anania G, Davies RJ, Bagolini F, Vettoretto N, Randolph J, Cirocchi R, Donini A. Right hemicolectomy with complete mesocolic excision is safe, leads to an increased lymph node yield and to increased survival: results of a systematic review and meta-analysis. Tech Coloproctol. 2021;25(10):1099–1113. 10.1007/s10151-021-02471-2. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
9. West NP, Morris EJA, Rotimi O, Cairns A, Finan PJ, Quirke P. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008;9:857–865. 10.1016/S1470-2045(08)70181-5. [Abstract] [CrossRef] [Google Scholar]
10. Kim NK, Kim YW, Han YD, Cho MS, Hur H, Min BS, et al. Complete mesocolic excision and central vascular ligation for colon cancer: principle, anatomy, surgical technique, and outcomes. Surg Oncol. 2016;25(3):252–262. 10.1016/j.suronc.2016.05.009. [Abstract] [CrossRef] [Google Scholar]
11. Tejedor P, Francis N, Jayne D, Hohenberger W, Khan J, on behalf the CME Project Working Group Consensus statements on complete mesocolic excision for right-sided colon cancer-technical steps and training implications. Surg Endosc. 2022;36(8):5595–5601. 10.1007/s00464-021-08395-0. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
12. Anania G, Agresta F, Artioli E, Rubino S, Resta G, Vettoretto N, Petz WL, Bergamini C, Arezzo A, Valpiani G, Morotti C, Silecchia G, SICE CoDIG (Colon Dx Italian Group) Laparoscopic right hemicolectomy: the SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective trial on 1225 cases comparing intra corporeal versus extra corporeal ileo-colic side-to-side anastomosis. Surg Endosc. 2020;34(11):4788–4800. 10.1007/s00464-019-07255-2. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
13. Balciscueta Z, Balciscueta I, Uribe N, Pellino G, Frasson M, García-Granero E, García-Granero Á. D3-lymphadenectomy enhances oncological clearance in patients with right colon cancer. Results of a meta-analysis. Eur J Surg Oncol. 2021;47(7):1541–1551. 10.1016/j.ejso.2021.02.020. [Abstract] [CrossRef] [Google Scholar]
14. Son GM, Lee IY, Lee YS, Kye BH, Cho HM, Jang JH, Kim CN, Lee KY, Lee SH, Kim JG, Korean Laparoscopic Colorectal Surgery Study Group Is laparoscopic complete mesocolic excision and central vascular ligation really necessary for all patients with right-sided colon cancer? Ann Coloproctol. 2021;37(6):434–444. 10.3393/ac.2021.00955.0136. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
15. Ueno H, Hase K, Shiomi A, Shiozawa M, Ito M, Sato T, Hashiguchi Y, Kusumi T, Kinugasa Y, Ike H, Matsuda K, Yamada K, Komori K, Takahashi K, Kanemitsu Y, Ozawa H, Ohue M, Masaki T, Takii Y, Ishibe A, Watanabe J, Toiyama Y, Sonoda H, Koda K, Akagi Y, Itabashi M, Nakamura T, Sugihara K. Optimal bowel resection margin in colon cancer surgery: prospective multicentre cohort study with lymph node and feeding artery mapping. Lancet Reg Health West Pac. 2023;33:100680. 10.1016/j.lanwpc.2022.100680. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
16. Benz S, Tannapfel A, Tam Y, Grünenwald A, Vollmer S, Stricker I. Proposal of a new classification system for complete mesocolic excison in right-sided colon cancer. Tech Coloproctol. 2019;23(3):251–257. 10.1007/s10151-019-01949-4. [Abstract] [CrossRef] [Google Scholar]
17. Kotake K, Honjo S, Sugihara K, Hashiguchi Y, Kato T, Kodaira S, et al. Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol. 2012;42(1):29–35. 10.1093/jjco/hyr164. [Abstract] [CrossRef] [Google Scholar]
18. Smalbroek BP, Smits AB, Khan JS. Safe oncological and standardised (“SOS”) right hemicolectomy for colon cancer. Tech Coloproctol. 2023;27(3):169–170. 10.1007/s10151-022-02749-z. [Abstract] [CrossRef] [Google Scholar]
19. Xu L, Su X, He Z, Zhang C, Lu J, Zhang G, et al. Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial. Lancet Oncol. 2021;22(3):391–401. 10.1016/S1470-2045(20)30685-9. [Abstract] [CrossRef] [Google Scholar]
20. Crane J, Hamed M, Borucki JP, El-Hadi A, Shaikh I, Stearns AT. Complete mesocolic excision versus conventional surgery for colon cancer: a systematic review and meta-analysis. Color Dis. 2021;23(7):1670–1686. 10.1111/codi.15644. [Abstract] [CrossRef] [Google Scholar]
21. Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K. The extent of lymph node dissection for colon carcinoma: the potential impact on laparoscopic surgery. Cancer. 1997;80(2):188–192. 10.1002/(SICI)1097-0142(19970715)80:2<188::AID-CNCR3>3.0.CO;2-Q. [Abstract] [CrossRef] [3.0.CO;2-Q&" target="pmc_ext" ref="reftype=other&article-id=9721827&issue-id=418863&journal-id=1297&FROM=Article%7CCitationRef&TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar]

Citations & impact 


Impact metrics

Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/158243459
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/158243459

Article citations

Data 


Data behind the article

This data has been text mined from the article, or deposited into data resources.

Similar Articles 


To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.


Funding 


Funders who supported this work.

Università degli Studi di Ferrara